10-15 Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $4.6M | Sell |
18,086
-718
| -4% | -$178K | 0.89% | 32 |
|
|
2020
Q2 | $4.43M | Buy |
18,804
+33
| +0.2% | +$7.53K | 0.89% | 30 |
|
|
2020
Q1 | $3.81M | Buy |
18,771
+630
| +3% | +$138K | 0.89% | 31 |
|
|
2019
Q4 | $4.37M | Sell |
18,141
-189
| -1% | -$41.7K | 0.83% | 32 |
|
|
2019
Q3 | $3.55M | Buy |
18,330
+268
| +1% | +$51.4K | 0.73% | 32 |
|
|
2019
Q2 | $3.33M | Buy |
18,062
+369
| +2% | +$66.1K | 0.72% | 32 |
|
|
2019
Q1 | $3.36M | Sell |
17,693
-131
| -0.7% | -$25K | 0.72% | 32 |
|
|
2018
Q4 | $3.47M | Sell |
17,824
-402
| -2% | -$78.4K | 0.85% | 29 |
|
|
2018
Q3 | $3.78M | Sell |
18,226
-2,422
| -12% | -$477K | 0.85% | 32 |
|
|
2018
Q2 | $3.81M | Buy |
20,648
+45
| +0.2% | +$7.96K | 0.86% | 32 |
|
|
2018
Q1 | $3.51M | Buy |
20,603
+327
| +2% | +$60K | 0.83% | 33 |
|
|
2017
Q4 | $3.53M | Buy |
20,276
+594
| +3% | +$105K | 0.84% | 33 |
|
|
2017
Q3 | $3.67M | Buy |
19,682
+850
| +5% | +$151K | 0.93% | 31 |
|
|
2017
Q2 | $3.24M | Sell |
18,832
-292
| -2% | -$47.5K | 0.91% | 32 |
|
|
2017
Q1 | $3.14M | Buy |
19,124
+328
| +2% | +$54.5K | 0.86% | 34 |
|
|
2016
Q4 | $2.75M | Buy |
18,796
+4,175
| +29% | +$628K | 0.77% | 34 |
|
|
2016
Q3 | $2.44M | Sell |
14,621
-62
| -0.4% | -$10.5K | 0.68% | 41 |
|
|
2016
Q2 | $2.23M | Buy |
14,683
+510
| +4% | +$79.3K | 0.64% | 42 |
|
|
2016
Q1 | $2.13M | Buy |
14,173
+2,610
| +23% | +$388K | 0.66% | 39 |
|
|
2015
Q4 | $1.88M | Buy |
11,563
+65
| +0.6% | +$10.2K | 0.55% | 52 |
|
|
2015
Q3 | $1.59M | Sell |
11,498
-5,192
| -31% | -$818K | 0.55% | 49 |
|
|
2015
Q2 | $2.56M | Sell |
16,690
-961
| -5% | -$154K | 0.79% | 35 |
|
|
2015
Q1 | $2.82M | Sell |
17,651
-118
| -0.7% | -$18.6K | 0.94% | 28 |
|
|
2014
Q4 | $2.83M | Sell |
17,769
-203
| -1% | -$31.6K | 0.91% | 30 |
|
|
2014
Q3 | $2.52M | Sell |
17,972
-277
| -2% | -$36.2K | 0.85% | 32 |
|
|
2014
Q2 | $2.16M | Sell |
18,249
-119
| -0.6% | -$13.8K | 0.68% | 38 |
|
|
2014
Q1 | $2.27M | Sell |
18,368
-421
| -2% | -$51.1K | 0.74% | 35 |
|
|
2013
Q4 | $2.14M | Sell |
18,789
-68
| -0.4% | -$7.74K | 0.74% | 33 |
|
|
2013
Q3 | $2.11M | Sell |
18,857
-68
| -0.4% | -$7.37K | 0.88% | 29 |
|
|
2013
Q2 | $1.87M | Buy |
+18,925
| New | +$1.96M | 0.86% | 30 |
|
Other funds holding AMGN
10-15 Associates's AMGN Position: Q3 2020 in Review
10-15 Associates reduced its Amgen (AMGN) stake by 3.8% in Q3 2020, selling an estimated $178K and leaving 18,086 shares worth $4.6M. The position accounts for 0.89% of the portfolio, ranked #32.
10-15 Associates first reported a position in AMGN in Q2 2013 and has held it in 30 quarters since. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.
- 10-15 Associates held 18,086 shares of Amgen worth $4.6M as of Q3 2020.
- 10-15 Associates sold 718 Amgen shares in Q3 2020, an estimated $178K.
- Amgen made up 0.89% of 10-15 Associates's portfolio in Q3 2020, its #32 holding.
- 10-15 Associates first reported a position in Amgen in Q2 2013 and has held it in 30 quarters since.
- 2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.
Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.